EDITAS MEDICINE, INC. Current Assets
EDITAS MEDICINE, INC. (EDIT) had Current Assets of $218.07 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-05
- 2026-06-30: Assets, Current $218.07M.
- 2026-03-31: Assets, Current $128.07M.
- 2025-12-31: Assets, Current $163.90M.
- 2025-09-30: Assets, Current $176.89M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $218.07M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $128.07M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $163.90M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $176.89M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $182.80M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $224.84M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $289.31M 10-K · filed 2026-03-09 |
| 2024-09-30 | $271.14M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $286.35M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $305.56M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $340.83M 10-K · filed 2025-03-05 |
| 2023-09-30 | $358.60M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $440.98M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $324.46M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $356.75M 10-K · filed 2024-02-28 |
| 2022-09-30 | $426.63M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $461.38M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $497.03M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $507.31M 10-K · filed 2023-02-22 |
| 2021-09-30 | $567.61M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $616.29M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $632.32M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $419.09M 10-K · filed 2022-02-24 |
| 2020-09-30 | $506.83M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $610.13M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $425.11M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $463.84M 10-K · filed 2021-02-26 |
| 2019-09-30 | $339.21M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $324.24M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $347.07M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $374.78M 10-K · filed 2020-02-26 |
| 2018-09-30 | $342.55M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $348.24M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $362.81M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $332.20M 10-K · filed 2019-03-01 |
| 2017-09-30 | $298.42M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $327.87M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $353.79M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $187.18M 10-K · filed 2018-03-08 |
| 2016-09-30 | $203.45M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $221.22M 10-Q · filed 2016-08-10 |
| 2016-03-31 | $232.19M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $144.99M 10-K · filed 2017-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |